基本資料
種類: ETF
費用比率%: 0.50
資產淨值: 34.85
成立日期: 07/10/2021
 
分析
市值分佈:
74.03%
大市值
14.25%
中市值
2.22%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 52  
0%
 
100%
     10大 (50.90%)
代號 名稱 佔比% 持有日期
ALGNAlign Technology8.1127/02/2026
LLYEli Lilly & Co7.0027/02/2026
CHGCFChugai Pharmaceutical Co., Ltd.5.2027/02/2026
REGNRegeneron Pharmaceuticals5.0127/02/2026
NVONovo-Nordisk A/S4.6627/02/2026
ABBVABBVIE4.5027/02/2026
JNJJohnson & Johnson4.4827/02/2026
BHVNBiohaven Ltd4.1327/02/2026
JAZZJazz Pharmaceuticals plc3.9227/02/2026
AMGNAmgen3.8827/02/2026
GILDGilead Sciences3.6527/02/2026
TXG10x Genomics3.2527/02/2026
WRBYWarby Parker2.9027/02/2026
MMM3M Company2.8627/02/2026
DHRDanaher Corp2.7227/02/2026
VRTXVertex Pharmaceuticals2.5227/02/2026
AZNAstraZeneca PLC2.1527/02/2026
EYPTEyePoint Inc.1.9127/02/2026
PCTPureCycle Technologies1.8427/02/2026
CVSCVS HEALTH Corp1.6727/02/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.